HIPEC in the Consolidation Setting: A Consolation Prize for Chemorefractory Ovarian Cancer?

Ann Surg Oncol. 2023 Jun;30(6):3177-3179. doi: 10.1245/s10434-023-13263-3. Epub 2023 Feb 22.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Combined Modality Therapy
  • Cytoreduction Surgical Procedures
  • Female
  • Humans
  • Hyperthermia, Induced*
  • Hyperthermic Intraperitoneal Chemotherapy
  • Ovarian Neoplasms* / drug therapy

Substances

  • Antineoplastic Agents